Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD53 |
| Upstream (Parents) |
|---|
| (<<) ITGB2 → CD53 |
| (<<) LAPTM5 → CD53 |
| (<<) FCER1G → CD53 |
| (<<) TYROBP → CD53 |
| (<<) HCK → CD53 |
| Downstream (Children) |
|---|
| CD53 → TAAR3 (>>) |
| CD53 → STX11 (>>) |
| CD53 → CD52 (>>) |
| CD53 → CD37 (>>) |
| CD53 → IL2RA (>>) |
| CD53 → FZD5 (>>) |
| CD53 → PTPRC (>>) |
| CD53 → CSF2RB (>>) |
| CD53 → EVI2B///EVI2A (>>) |
| CD53 → CCL4 (>>) |
| CD53 → EVI2B (>>) |
| CD53 → ITGB2 (>>) |
| CD53 → FCGR1B (>>) |
| CD53 → NCF2 (>>) |
| CD53 → IFI30 (>>) |
| CD53 → TFEC (>>) |
| CD53 → LAPTM5 (>>) |
| CD53 → FCER1G (>>) |
| CD53 → CSF3R (>>) |
| CD53 → CLEC7A (>>) |
| CD53 → SRGN (>>) |
| CD53 → CD86 (>>) |
| CD53 → HCK (>>) |
| CD53 → GLIPR1 (>>) |
| CD53 → VAV1 (>>) |
| CD53 → SLA (>>) |
| CD53 → PSTPIP1 (>>) |
| CD53 → PLEK (>>) |
| CD53 → TRPV2 (>>) |
| CD53 → FGR (>>) |
| CD53 → RUNX3 (>>) |
| CD53 → CCR1 (>>) |
| CD53 → SLC7A7 (>>) |
| CD53 → ARHGDIB (>>) |
| CD53 → SASH3 (>>) |
| CD53 → HLA-C (>>) |
